hyaluronidase

FDA Drug Profile — AMPHADASE

hyaluronidase is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including AMPHADASE. Available dosage form: injection.

Drug details

Generic Name
hyaluronidase
Brand Names
AMPHADASE
Application Number
BLA021665
Sponsor
Amphastar Pharmaceuticals, Inc.
NDC Codes
1
Dosage Forms
INJECTION
Routes
SUBCUTANEOUS
Active Ingredients
HYALURONIDASE

Indications and Usage

1. Indications and Usage HYLENEX recombinant is an endoglycosidase indicated as an adjuvant in subcutaneous fluid administration for achieving hydration ( 1.1 ) to increase the dispersion and absorption of other injected drugs ( 1.2 ) in subcutaneous urography for improving resorption of radiopaque agents ( 1.3 ) 1.1. Subcutaneous Fluid Administration HYLENEX recombinant is indicated as an adjuvant in subcutaneous fluid administration for achieving hydration. 1.2. Dispersion and Absorption of Injected Drugs HYLENEX recombinant is indicated as an adjuvant to increase the dispersion and absorption of other injected drugs. 1.3. Subcutaneous Urography HYLENEX recombinant is indicated as an adjunct in subcutaneous urography for improving resorption of radiopaque agents.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.